India Parkinsons Disease Market (2025-2031) | Share, Forecast, Companies, Competitive Landscape, Segmentation, Size & Revenue, Outlook, Trends, Value, Growth, Analysis, Industry

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 India Country Macro Economic Indicators

3.2 India Parkinsons Disease Market Revenues & Volume, 2021 & 2031F

3.3 India Parkinsons Disease Market - Industry Life Cycle

3.4 India Parkinsons Disease Market - Porter's Five Forces

3.5 India Parkinsons Disease Market Revenues & Volume Share, By Drug Class, 2021 & 2031F

3.6 India Parkinsons Disease Market Revenues & Volume Share, By Medical Devices, 2021 & 2031F

3.7 India Parkinsons Disease Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F

3.8 India Parkinsons Disease Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F

3.9 India Parkinsons Disease Market Revenues & Volume Share, By Patient Care Setting, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing aging population in India

4.2.2 Growing awareness about Parkinson's disease and its diagnosis

4.2.3 Advancements in medical technology for Parkinson's treatment

4.3 Market Restraints

4.3.1 Lack of access to specialized healthcare facilities in rural areas

4.3.2 High cost of Parkinson's disease medications and treatments

4.3.3 Limited research and development in India specific to Parkinson's disease

6.1 India Parkinsons Disease Market, By Drug Class

6.1.1 Overview and Analysis

6.1.2 India Parkinsons Disease Market Revenues & Volume, By Drug Class, 2021- 2031F

6.1.3 India Parkinsons Disease Market Revenues & Volume, By Levodopa/Carbidopa, 2021- 2031F

6.1.4 India Parkinsons Disease Market Revenues & Volume, By Dopamine Receptor Agonists, 2021- 2031F

6.1.5 India Parkinsons Disease Market Revenues & Volume, By MAO-Inhibitors, 2021- 2031F

6.1.6 India Parkinsons Disease Market Revenues & Volume, By COMT-Inhibitors, 2021- 2031F

6.1.7 India Parkinsons Disease Market Revenues & Volume, By Anticholinergics, 2021- 2031F

6.1.8 India Parkinsons Disease Market Revenues & Volume, By Other Drugs, 2021- 2031F

6.2 India Parkinsons Disease Market, By Medical Devices

6.2.1 Overview and Analysis

6.2.2 India Parkinsons Disease Market Revenues & Volume, By Deep Brain Stimulation (DBS) Devices, 2021- 2031F

6.2.3 India Parkinsons Disease Market Revenues & Volume, By Carbidopa/Levodopa Enteral Suspension (Duopa) Delivery Devices, 2021- 2031F

6.3 India Parkinsons Disease Market, By Route of Administration

6.3.1 Overview and Analysis

6.3.2 India Parkinsons Disease Market Revenues & Volume, By Oral, 2021- 2031F

6.3.3 India Parkinsons Disease Market Revenues & Volume, By Transdermal, 2021- 2031F

6.3.4 India Parkinsons Disease Market Revenues & Volume, By Subcutaneous, 2021- 2031F

6.3.5 India Parkinsons Disease Market Revenues & Volume, By Intestinal Infusion, 2021- 2031F

6.3.6 India Parkinsons Disease Market Revenues & Volume, By Others, 2021- 2031F

6.4 India Parkinsons Disease Market, By Distribution Channel

6.4.1 Overview and Analysis

6.4.2 India Parkinsons Disease Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F

6.4.3 India Parkinsons Disease Market Revenues & Volume, By Clinics, 2021- 2031F

6.4.4 India Parkinsons Disease Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F

6.4.5 India Parkinsons Disease Market Revenues & Volume, By Online Pharmacies, 2021- 2031F

6.5 India Parkinsons Disease Market, By Patient Care Setting

6.5.1 Overview and Analysis

6.5.2 India Parkinsons Disease Market Revenues & Volume, By Hospitals, 2021- 2031F

6.5.3 India Parkinsons Disease Market Revenues & Volume, By Clinics, 2021- 2031F

7.1 India Parkinsons Disease Market Export to Major Countries

7.2 India Parkinsons Disease Market Imports from Major Countries

8.1 Number of Parkinson's disease awareness campaigns conducted annually

8.2 Percentage increase in the number of neurologists specializing in movement disorders

8.3 Average wait time for Parkinson's disease diagnosis in major cities

9.1 India Parkinsons Disease Market Opportunity Assessment, By Drug Class, 2021 & 2031F

9.2 India Parkinsons Disease Market Opportunity Assessment, By Medical Devices, 2021 & 2031F

9.3 India Parkinsons Disease Market Opportunity Assessment, By Route of Administration, 2021 & 2031F

9.4 India Parkinsons Disease Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F

9.5 India Parkinsons Disease Market Opportunity Assessment, By Patient Care Setting, 2021 & 2031F

10.1 India Parkinsons Disease Market Revenue Share, By Companies, 2024

10.2 India Parkinsons Disease Market Competitive Benchmarking, By Operating and Technical Parameters